Dimensional Fund Advisors LP Acquires 120,330 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Dimensional Fund Advisors LP lifted its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 8.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,558,158 shares of the medical device company's stock after buying an additional 120,330 shares during the quarter. Dimensional Fund Advisors LP owned about 0.78% of Cooper Companies worth $143,234,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the company. Forum Financial Management LP raised its position in shares of Cooper Companies by 107.3% in the fourth quarter. Forum Financial Management LP now owns 3,840 shares of the medical device company's stock valued at $353,000 after buying an additional 1,988 shares in the last quarter. Capital International Sarl boosted its holdings in shares of Cooper Companies by 32.8% during the 4th quarter. Capital International Sarl now owns 3,882 shares of the medical device company's stock valued at $357,000 after acquiring an additional 958 shares in the last quarter. Canada Pension Plan Investment Board boosted its stake in shares of Cooper Companies by 6.2% during the fourth quarter. Canada Pension Plan Investment Board now owns 199,170 shares of the medical device company's stock valued at $18,310,000 after purchasing an additional 11,568 shares in the last quarter. Farringdon Capital Ltd. bought a new stake in Cooper Companies during the 4th quarter worth approximately $380,000. Finally, Guggenheim Capital LLC increased its holdings in Cooper Companies by 33.1% in the fourth quarter. Guggenheim Capital LLC now owns 6,808 shares of the medical device company's stock valued at $626,000 after purchasing an additional 1,694 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have issued reports on COO. Robert W. Baird lowered their price target on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a report on Friday, March 7th. BNP Paribas upgraded shares of Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Piper Sandler reissued an "overweight" rating and set a $115.00 target price (down from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a research note on Friday, March 7th. Finally, Stifel Nicolaus decreased their price target on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Cooper Companies presently has a consensus rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Trading Down 0.8 %

Shares of NASDAQ:COO traded down $0.69 on Thursday, reaching $80.98. 317,247 shares of the company traded hands, compared to its average volume of 1,421,592. The Cooper Companies, Inc. has a 52 week low of $69.81 and a 52 week high of $112.38. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The business's 50-day simple moving average is $81.78 and its 200 day simple moving average is $92.27. The stock has a market capitalization of $16.19 billion, a P/E ratio of 41.61, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. As a group, equities analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.